Medicinal Cannabis Scheme Impact Assessment

Regulatory impact statement

Publication Date: 
11 December 2019

The Medicinal Cannabis Scheme enables domestic cultivation and manufacture of medicinal cannabis, and the import of overseas products. Regulations specific to medicinal cannabis are required to establish the scheme. These will set minimum quality standards for products, and set medicinal cannabis licensing requirements.

The impact assessment provides supporting analysis for the Cabinet paper seeking approval for policy decisions required to draft the medicinal cannabis regulations.

Regulatory impact statements

Back to top